MEI Pharma gains on unsolicited buyout bid from Anson Funds
** Shares of MEI Pharma Inc MEIP.O up 8% at $7.93 in
after-market trade
** Co confirms receipt of unsolicited acquisition proposal
from group of investors led by Anson Funds Management LP
** The proposal is to acquire all shares of MEIP for a cash
consideration of not less than $8.00/shr, plus contingent value
right
** Anson Funds reported an about 10% stake in MEIP as of
May 19, according to SEC filing
** As of last close, MEIP shares had gained ~48% YTD
(Reporting by Ankit Kumar)
((Ankit.Kumar2@thomsonreuters.com))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations